Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. Freeman MW, Halvorsen YD, Marshall W, Pater M, et al. N Engl J Med 2022 Nov 7. doi: 10.1056/NEJMoa2213169.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Freeman MW, Halvorsen YD, Marshall W, Pater M, et al. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. N Engl J Med 2022 Nov 7. doi: 10.1056/NEJMoa2213169.
PMID: 36342143